Arnab Sarkar

Statistics

Publications

Citations

317

H-Index

Active since

2016

Affiliations

Minneapolis VA Medical Center(Current)

Ospedale Papa Giovanni XXIII

University of Glasgow

Tris Pharma (United States)

Novartis (United States)

Arnab Sarkar is an author at Minneapolis VA Medical Center specializing in heart failure pharmacotherapy, pharmacotherapy, and cardiovascular pharmacotherapy.

ORCID

Publications per year

2016–2023

Publications

Initiating Sacubitril/Valsartan (LCZ696) in Heart Failure: Results of TITRATION, a Double-Blind, Randomized Comparison of Two Uptitration Regimens

Michele Senni, John J.V. McMurray, Rolf Wachter et al. · European Journal of Heart Failure · 2016 · 236 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Impact of Systolic Blood Pressure on the Safety and Tolerability of Initiating and Up-Titrating Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the TITRATION Study

Michele Senni, John J.V. McMurray, Rolf Wachter et al. · European Journal of Heart Failure · 2017 · 70 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +11

Efficacy and safety of eliapixant in diabetic neuropathic pain and prediction of placebo responders with an exploratory novel algorithm: results from the randomized controlled phase 2a PUCCINI study

Didier Bouhassira, Solomon Tesfaye, Arnab Sarkar et al. · Pain · 2023 · 11 citations

Medicine, Pharmacology, Pharmacotherapy +17

1–3 of 3